Idorsia's IPO

Idorsia raised a round of funding on June 16, 2017. Investors include Public.

Idorsia (SIX: IDIA) is a drug discovery and early-stage clinical pipeline company. Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic o…

Articles about Idorsia's IPO: